Myocardial adrenergic dysinnervation in dilated cardiomyopathy: cornerstone or epiphenomenon?
Merlet
Pascal
P
Centre Hospitalo-Universitaire Henri Mondor Université Paris XII, Créteil, Val de Marne, France.
Hittinger
Luc
L
Dubois-Randé
Jean Luc
JL
Castaigne
Alain
A
D019797:3-Iodobenzylguanidine; D000320:Adrenergic Fibers / Q000473:pathology / Q000502:physiology*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000818:Animals; D002227:Carbazoles / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology*; D000077261:Carvedilol; D006321:Heart / Q000294:innervation*; D009205:Myocarditis / Q000150:complications; D011412:Propanolamines / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D051381:Rats
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D019275:Radiopharmaceuticals; D000077261:Carvedilol; D019797:3-Iodobenzylguanidine